DrugPatentWatch Database Preview
Drugs in Development Information for Seltorexant
Email this page to a colleague
See Plans and PricingWhat is the development status for investigational drug Seltorexant?
Seltorexant is an investigational drug.
There have been 5 clinical trials for Seltorexant.
The most recent clinical trial was a Phase 1 trial, which was initiated on September 1st 2017.
The most common disease conditions in clinical trials are Apnea, Disease, and Depressive Disorder, Major. The leading clinical trial sponsors are Janssen Research & Development, LLC, Minerva Neurosciences, and [disabled in preview].
There are three US patents protecting this investigational drug and fifty-two international patents.
Summary for Seltorexant
| US Patents | 3 |
| International Patents | 52 |
| US Patent Applications | 6 |
| WIPO Patent Applications | 2 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 1 (2017-09-01) |
| Vendors | 7 |
Recent Clinical Trials for Seltorexant
| Title | Sponsor | Phase |
|---|---|---|
| A Study to Assess the Effect of Seltorexant Compared to Placebo on Respiration During Sleep in Adult Participants With Obstructive Sleep Apnea | Janssen Research & Development, LLC | Phase 1 |
| A Study of Seltorexant (JNJ-42847922) After Single-Dose Administration in Healthy Participants | Minerva Neurosciences | Phase 1 |
| A Study of Seltorexant (JNJ-42847922) After Single-Dose Administration in Healthy Participants | Janssen Research & Development, LLC | Phase 1 |
Clinical Trial Summary for Seltorexant
Top disease conditions for Seltorexant
Top clinical trial sponsors for Seltorexant
US Patents for Seltorexant
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Seltorexant | Start Trial | Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators | Janssen Pharmaceutica (BE) | Start Trial |
| Seltorexant | Start Trial | Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators | Janssen Pharmaceutica NV (BE) | Start Trial |
| Seltorexant | Start Trial | Disubstituted octahydropyrrolo [3,4-C] pyrroles as orexin receptor modulators | Janssen Pharmaceutica NV (Beerse, BE) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Seltorexant
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Seltorexant | Argentina | 078731 | 2029-10-23 | Start Trial |
| Seltorexant | Australia | 2010310595 | 2029-10-23 | Start Trial |
| Seltorexant | Australia | 2015242975 | 2029-10-23 | Start Trial |
| Seltorexant | Brazil | 112012010820 | 2029-10-23 | Start Trial |
| Seltorexant | Canada | 2778484 | 2029-10-23 | Start Trial |
| Seltorexant | Chile | 2010001162 | 2029-10-23 | Start Trial |
| Seltorexant | China | 102781942 | 2029-10-23 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
